









Markets
/
Stocks
/
nasdaq-icui
/

ICU Medical Inc

ICUI

154.160USD

+4.520+3.02%

Close 02/06, 16:00（ET）Quotes delayed by 15 min

3.81BMarket Cap

LossP/E TTM



ICU Medical Inc

154.160

+4.520+3.02%

Overview Financials Analysis Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Financials

Analysis

Company

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of ICU Medical Inc

Currency: USD Updated: 2026-02-06

Key Insights

ICU Medical Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 39 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 181.40.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

ICU Medical Inc's Score

Industry at a Glance

Industry Ranking

39 / 205

Overall Ranking

127 / 4521

Industry

Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

ICU Medical Inc Highlights

StrengthsRisks

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 2.38B.

Undervalued

The company’s latest PE is -509.11, at a low 3-year percentile range.

Institutional Buying

The latest institutional holdings are 29.13M shares, increasing 6.47% quarter-over-quarter.

Held by Joel Greenblatt

Star Investor Joel Greenblatt holds 41.04K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.36.

Analyst Rating

Based on 6 analysts

Buy

Current Rating

181.400

Target Price

+21.22%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-02-06

The current financial score of ICU Medical Inc is 6.41, ranking 155 out of 205 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 536.99M, representing a year-over-year decrease of 8.85%, while its net profit experienced a year-over-year decrease of 89.70%.

Score

Industry at a Glance

Previous score

6.41

Change



Financials

6.82

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

2.45

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

8.58

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

7.08

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

7.14

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

ICU Medical Inc's Company Valuation

Currency: USD Updated: 2026-02-06

The current valuation score of ICU Medical Inc is 8.38, ranking 23 out of 205 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -509.11, which is -94.71% below the recent high of -26.95 and -2.84% above the recent low of -523.58.

Score

Industry at a Glance

Previous score

8.38

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 39/205

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-02-06

The current earnings forecast score of ICU Medical Inc is 8.33, ranking 43 out of 205 in the Healthcare Equipment & Supplies industry. The average price target is 180.00, with a high of 200.00 and a low of 172.00.

Score

Industry at a Glance

Previous score

8.33

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 6 analysts

Buy

Current Rating

181.400

Target Price

+21.22%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

114

Total

Median

Average

Company name

Ratings

Analysts

ICU Medical Inc

ICUI

Stryker Corp

SYK

Abbott Laboratories

ABT

Medtronic PLC

MDT

Dexcom Inc

DXCM

Zimmer Biomet Holdings Inc

ZBH

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-02-06

The current price momentum score of ICU Medical Inc is 6.87, ranking 77 out of 205 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 160.86 and the support level at 146.90, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

6.38

Change

0.49

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.722

Neutral

RSI(14)

57.812

Neutral

STOCH(KDJ)(9,3,3)

56.956

Buy

ATR(14)

4.792

High Vlolatility

CCI(14)

13.553

Neutral

Williams %R

45.610

Neutral

TRIX(12,20)

0.083

Sell

StochRSI(14)

100.000

Buy

Moving Average

Sell(0)

Neutral(0)

Buy(6)

Indicators

Value

Direction

MA5

151.184

Buy

MA10

150.726

Buy

MA20

151.955

Buy

MA50

148.665

Buy

MA100

137.344

Buy

MA200

133.846

Buy

Institutional Confidence

Currency: USD Updated: 2026-02-06

The current institutional shareholding score of ICU Medical Inc is 10.00, ranking 1 out of 205 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 117.99%, representing a quarter-over-quarter increase of 4.42%. The largest institutional shareholder is The Vanguard, holding a total of 2.71M shares, representing 10.97% of shares outstanding, with 2.42% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

3.22M

-1.30%

The Vanguard Group, Inc.

Star Investors

2.62M

-1.26%

Janus Henderson Investors

2.47M

+0.14%

Wasatch Global Investors Inc

Star Investors

2.47M

Fuller & Thaler Asset Management Inc.

1.39M

-0.35%

Millennium Management LLC

1.09M

+173.40%

State Street Investment Management (US)

917.13K

-1.15%

Dimensional Fund Advisors, L.P.

872.99K

+16.88%

Schroder Investment Management North America Inc.

796.70K

+25.20%

Columbia Threadneedle Investments (US)

763.73K

+32.48%

Risk Assessment

Currency: USD Updated: 2026-02-06

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of ICU Medical Inc is 7.52, ranking 38 out of 205 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.80. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.